Lv63
3150 积分 2022-05-18 加入
The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future
1个月前
已完结
Cardiac MRI optimizes risk stratification accuracy in connective tissue disease-associated pulmonary arterial hypertension: a retrospective cohort study
1个月前
已完结
Long-Term Prospective Observation Study of Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
1个月前
已完结
Immunosuppressive therapy in patients with connective tissue disease‐associated pulmonary arterial hypertension: A systematic review
1个月前
已完结
Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension
3个月前
已完结
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbidities
4个月前
已完结
Recommendations for Prevention and Control of Influenza in Children, 2024–2025: Policy Statement
6个月前
已完结
Effectiveness and persistence with selexipag in pulmonary arterial hypertension in the real-life setting
6个月前
已完结
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel
6个月前
已完结
Evaluating oral selexipag in PAH: Insights on survival, safety and dosing patterns from the complete observation period of GRIPHON and its open-label extension
6个月前
已完结
皖公网安备34019202002308
